{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:11:55Z","timestamp":1790115115075,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1155669"],"award-info":[{"award-number":["1155669"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001801","name":"University of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jamda.2023.06.037","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T15:54:31Z","timestamp":1691510071000},"page":"1311.e1-1311.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of a Multifaceted, Pharmacist-Led Intervention on Psychotropic Medication Use for Residents of Aged Care Facilities: A Parallel Cluster Randomized Controlled Trial"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1326-6943","authenticated-orcid":false,"given":"Hend","family":"Almutairi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Stafford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Etherton-Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Flicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2023.06.037_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11920-019-1049-5","article-title":"Management of behavioral and psychological symptoms of dementia","volume":"21","author":"Bessey","year":"2019","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.jamda.2023.06.037_bib3","first-page":"161","article-title":"The prevalence and course of neuropsychiatric symptoms in nursing home patients with dementia: a systematic review","volume":"14","author":"Selb\u00e6k","year":"2013","journal-title":"JAMDA"},{"key":"10.1016\/j.jamda.2023.06.037_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12888-019-2291-4","article-title":"Reducing inappropriate psychotropic drug use in nursing home residents with dementia: protocol for participatory action research in a stepped-wedge cluster randomized trial","volume":"19","author":"Groot Kormelinck","year":"2019","journal-title":"BMC Psychiatr"},{"key":"10.1016\/j.jamda.2023.06.037_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/0004867418758919","article-title":"More action needed: psychotropic prescribing in Australian residential aged care","volume":"53","author":"Westbury","year":"2019","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.jamda.2023.06.037_bib6","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.npp.1301492","article-title":"ACNP white paper: update on use of antipsychotic drugs in Elderly persons with dementia","volume":"33","author":"Jeste","year":"2008","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2023.06.037_bib7","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1017\/S104161021600082X","article-title":"Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study","volume":"28","author":"Van der Spek","year":"2016","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2023.06.037_bib8","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1017\/S1041610211000445","article-title":"Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries","volume":"23","author":"Snowdon","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2023.06.037_bib9","first-page":"398","article-title":"RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities","volume":"208","author":"Westbury","year":"2018","journal-title":"MJA (Med J Aust)"},{"key":"10.1016\/j.jamda.2023.06.037_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1017\/S1041610217002447","article-title":"A\u00a0cross-sectional examination of the prevalence of psychotropic medications for people living with dementia in Australian long-term care facilities: issues of concern","volume":"30","author":"McMaster","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2023.06.037_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.5694\/mja12.11593","article-title":"Rethinking psychotropics in nursing homes","volume":"198","author":"Hilmer","year":"2013","journal-title":"Med J Aust"},{"key":"10.1016\/j.jamda.2023.06.037_bib12","first-page":"2140","article-title":"Pattern of prescription of psychotropics (antipsychotics, antidepressants and benzodiazepines) in Western Australian residential aged care facilities","volume":"51","author":"Almutairi","year":"2021","journal-title":"IMJ"},{"key":"10.1016\/j.jamda.2023.06.037_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/S1041610209991128","article-title":"An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project","volume":"22","author":"Westbury","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2023.06.037_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-020-01634-4","article-title":"Optimisation of medications used in residential aged care facilities: a systematic review and meta-analysis of randomised controlled trials","volume":"20","author":"Almutairi","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2023.06.037_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ageing\/afq161","article-title":"Interventions to optimise prescribing in care homes: systematic review","volume":"40","author":"Loganathan","year":"2011","journal-title":"Age Ageing"},{"key":"10.1016\/j.jamda.2023.06.037_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002500","article-title":"Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: a cluster-randomised controlled trial","volume":"15","author":"Ballard","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.jamda.2023.06.037_bib18","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/jgs.18276","article-title":"Unintended impacts of a national antipsychotic reduction initiative among nursing facility residents with and without Alzheimer's disease","volume":"71","author":"Wastila","year":"2023","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2023.06.037_bib19","article-title":"Rationalising antipsychotic prescribing in dementia (RAPID) complex intervention: a mixed-methods feasibility intervention study","volume":"8","author":"Walsh","year":"2022","journal-title":"Explor Res Clin Soc Pharm"},{"key":"10.1016\/j.jamda.2023.06.037_bib20","doi-asserted-by":"crossref","first-page":"e045787","DOI":"10.1136\/bmjopen-2020-045787","article-title":"Use of psychotropic drugs and drugs with anticholinergic properties among residents with dementia in intermediate care facilities for older adults in Japan: a cohort study","volume":"11","author":"Hamada","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2023.06.037_bib22","first-page":"1","article-title":"Aged care staff perceptions of an online training program for responsive behaviours of residents with dementia","volume":"20","author":"Almutairi","year":"2021","journal-title":"Austalas J Ageing"},{"issue":"suppl_1","key":"10.1016\/j.jamda.2023.06.037_bib24","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jamda.2023.06.037_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","article-title":"Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials","volume":"180","author":"Hayasaka","year":"2015","journal-title":"Affect. Disord"},{"key":"10.1016\/j.jamda.2023.06.037_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3928\/00989134-20160701-01","article-title":"Assessing health practitioner knowledge of appropriate psychotropic medication use in nursing homes: Validation of the older age psychotropic quiz","volume":"42","author":"Brown","year":"2016","journal-title":"J\u00a0Gerontol Nurs"},{"key":"10.1016\/j.jamda.2023.06.037_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"\u2217Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.jamda.2023.06.037_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jclinepi.2015.08.015","article-title":"Sample size calculations for stepped wedge and cluster randomised trials: a unified approach","volume":"69","author":"Hemming","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jamda.2023.06.037_bib31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5694\/mja2.50501","article-title":"The dispensing of psychotropic medicines to older people before and after they enter residential aged care","volume":"212","author":"Harrison","year":"2020","journal-title":"Med J Aust"},{"key":"10.1016\/j.jamda.2023.06.037_bib32","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jamda.2014.04.002","article-title":"Education to reduce potentially harmful medication use among residents of assisted living facilities: a randomized controlled trial","volume":"15","author":"Pitkala","year":"2014","journal-title":"J Am Med Direct Assoc"},{"key":"10.1016\/j.jamda.2023.06.037_bib33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1177\/1060028019866927","article-title":"Emergency department visits for psychotropic-related adverse drug events in older adults with Alzheimer disease, 2013\u20132014","volume":"53","author":"Sepassi","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jamda.2023.06.037_bib34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s40266-022-00982-7","article-title":"Association of psychotropic education with quality of life: a before-after study in residential aged care facilities","volume":"39","author":"Almutairi","year":"2022","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2023.06.037_bib35","article-title":"Knowledge Translation in Health Care","volume":"2","author":"Straus","year":"2013"},{"key":"10.1016\/j.jamda.2023.06.037_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jamda.2020.04.033","article-title":"Rates of PRN medication administration in Australian residential aged care","volume":"22","author":"Picton","year":"2021","journal-title":"J Am Med Direct Assoc"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861023006278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861023006278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:31:54Z","timestamp":1761507114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861023006278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1525861023006278"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2023.06.037","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a Multifaceted, Pharmacist-Led Intervention on Psychotropic Medication Use for Residents of Aged Care Facilities: A Parallel Cluster Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2023.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}